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ABSTRACT We provide novel evidence that the sarcoplasmic reticulum calcium binding protein, calsequestrin, inhibits
native ryanodine receptor calcium release channel activity. Calsequestrin dissociation from junctional face membrane was
achieved by increasing luminal (trans) ionic strength from 250 to 500 mM with CsCl or by exposing the luminal side of
ryanodine receptors to high [Ca2] (13 mM) and dissociation was confirmed with sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and Western blotting. Calsequestrin dissociation caused a 10-fold increase in the duration of ryanodine
receptor channel opening in lipid bilayers. Adding calsequestrin back to the luminal side of the channel after dissociation
reversed this increased activity. In addition, an anticalsequestrin antibody added to the luminal solution reduced ryanodine
receptor activity before, but not after, calsequestrin dissociation. A population of ryanodine receptors (35%) may have
initially lacked calsequestrin, because their activity was high and was unaffected by increasing ionic strength or by
anticalsequestrin antibody: their activity fell when purified calsequestrin was added and they then responded to antibody. In
contrast to native ryanodine receptors, purified channels, depleted of triadin and calsequestrin, were not inhibited by
calsequestrin. We suggest that calsequestrin reduces ryanodine receptor activity by binding to a coprotein, possibly to the
luminal domain of triadin.
INTRODUCTION
Contraction in skeletal and cardiac muscle is initiated by a
cascade of events collectively known as excitation-contrac-
tion coupling, in which depolarization of the sarcolemma
triggers Ca2 release through ryanodine receptor (RyR)
Ca2 release channels in the sarcoplasmic reticulum (SR).
Releasable Ca2 is loosely bound to, and stored on, a
glycoprotein calsequestrin (CSQ), which is located within
the SR lumen. CSQ is highly acidic with a moderate affinity
(KD  4  10
5 M) and high capacity (40–50 mol Ca2/
mol CSQ) for Ca2 (MacLennan and Wong, 1971).
CSQ monomers form a linear polymer that is tethered
through accessory proteins to the RyR (Costello et al., 1986)
and can be visualized in thin section electron micrographs,
where it appears to be anchored to the junctional face
membrane (JFM) (Franzini-Armstrong et al., 1987). An-
choring to the JFM and the RyR occurs via triadin and
junctin (Jones et al., 1995; Zhang et al., 1997; Mitchell et
al., 1988). Like calmodulin, CSQ monomers undergo a
conformational change upon Ca2 binding, resulting in
compaction and folding with an associated increase in -he-
lical content (Ikemoto et al., 1972). The Ca2-induced fold-
ing of monomeric CSQ is followed by aggregation into a
polymer (He et al., 1993; Wang et al., 1998). Amino acids
354 to 367, a region near the N-terminus of CSQ, is rich in
aspartate residues and is thought to form the binding site for
triadin (Zhang et al., 1997; Wang et al., 1998; Shin et al.,
2001). Another region near the N-terminus of CSQ is
thought to form a binding site for junctin (Wang et al., 1998;
Zhang et al., 1997).
Both triadin and junctin span the SR membrane, both
bind to CSQ and the RyR, and both share structural simi-
larities and significant sequence homology (Mitchell et al.,
1988; Guo et al., 1996; Knudson et al., 1993; Jones et al.,
1995; Zhang et al., 1997). The binding site on triadin for
CSQ has recently been localized to a KEKE motif at amino
acids 210 to 224 (multiple alternate lysine and glutamic acid
residues), whereas junctin is thought to have several sites
involved in CSQ binding (Kobayashi et al., 2001). A bind-
ing site for CSQ on the RyR has not yet been identified.
Several reports show that CSQ activates purified RyRs
(Szegedi et al., 1999; Herzog et al., 2000). The effect of
CSQ on native RyRs is more controversial because the
calcium binding protein has been variously reported to
activate (Kawasaki and Kasai, 1994; Ohkura et al., 1995) or
inhibit RyR channel activity (Beard et al., 1999, 2000;
Wang et al., 2001). Because the conformation of CSQ
changes over the physiological range of luminal [Ca2]
(Ikemoto et al., 1989), it has been suggested that CSQ plays
a role in regulating RyR activity in response to changes in
luminal [Ca2] (Donoso et al., 1995; Yamaguchi et al.,
1995).
Here we examine the effects of CSQ dissociation and
reassociation on single channel activity under carefully con-
trolled conditions. The results show that 1) CSQ dissocia-
tion enhances native RyR activity, while CSQ binding sup-
presses channel opening, 2) CHAPS solubilized RyRs
(without triadin and presumably junctin) showed a marginal
increase in activity when exposed to CSQ, and 3) antibody
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binding to CSQ further inhibits native RyR channel activity.
Preliminary results have been presented (Beard et al., 1999,
2000).
MATERIALS AND METHODS
Materials
The polyclonal anti-CSQ antibody was obtained from Swant Chemicals,
(Bellinzona, Switzerland). Other chemicals were from Sigma-Aldrich
(Castle Hill, Australia).
SR vesicles
Back and leg muscles were removed from New Zealand white rabbits and
SR vesicles prepared using methods of Saito et al. (1984) with minor
changes (Ahern et al., 1994). Briefly, the muscle was differentially centri-
fuged to yield a crude microsomal fraction, which was fractionated by
loading onto a discontinuous sucrose gradient. Heavy SR vesicles were
collected from the 35 to 45% (wt/vol) interface, centrifuged, resuspended
in buffer, then snap frozen, and stored in liquid N2 or at 70°C.
RyR purification
RyRs were purified from SR vesicles using methods of Lai et al. (1988).
SR vesicles were incubated at room temperature for 2 h in a solubilization
medium containing: 25 mM Pipes, 1 M NaCl, 0.5% CHAPS, 0.25%
phosphatidylcholine (PC), with protease inhibitors (0.8 mM benzamadine,
0.1 mM phenylmethylsulfonyl fluoride (PMSF), 1 g/ml leuopeptin, and
0.6 g/ml pepstatin A). After centrifugation for 15 min at 100,000 g, the
supernatant was applied to a sucrose gradient of between 5 to 25% and
ultracentrifuged at 80,000 g for 16 h. Fractions enriched with RyRs were
collected and RyRs visualized after sodium dodecyl sulfate-polyacrylam-
ide gel electrophoresis (SDS-PAGE) and Western blotting. Fractions en-
riched with RyR were concentrated by centrifugation at 5000  g for 30
min in a centricon-30 centrifugal concentrator and then dialysed overnight
against: 500 mM NaCl, 10 mM NaPipes, 1 mM dithiothreitol, 100 M
EGTA, 200 M CaCl2, and 1.5 M PMSF (pH 7.4) at 4°C. Aliquots
(200 l) were stored frozen at 70°C.
Calsequestrin purification
JFM was isolated as described Kim et al. (1983). Briefly, 200 g of chopped
muscle was homogenized in a Waring Blender in 800 ml of a solution
containing 2.5 mM NaOH and 20 mM MES (pH 6.8), centrifuged at
10,000  g for 3 min, the supernatant filtered, centrifuged twice at 17
000  g for 30 min, and the heavy SR pellet collected. CSQ was isolated
as described by Ikemoto et al. (1972, 1989). SR was suspended in a
solution containing 0.3 M sucrose, 20 mM MES (pH 6.8) plus protease
inhibitors (0.5 mM PMSF, 1 g/ml leupeptin, 1 g/ml pepstatin A, 1 mM
benzamadine), solubilized in 0.5% Triton X-100 (at 0°C), and centrifuged
at 350,000  g for 15 min. The pellet was homogenized in 500 mM NaCl,
20 mM MES (pH 6.8) plus protease inhibitors (above) to dissociate CSQ
from JFM. JFM was removed by centrifugation at 350,000 g for 15 min.
The supernatant was dialyzed twice overnight at 4°C against milliQ water
to remove residual Triton X-100, concentrated by centrifugation at 5000
g for 30 min in a centricon-30 centrifugal concentrator, resuspended at 1
mg/ml in 10 mM TES, 100 mM KCl, and 1 mM CaCl2, and stored in 20-l
aliquots at 70°C.
To demonstrate selective dissociation of CSQ from solubilized SR using
high [Ca2] on SDS-PAGE and Western blots, the following alterations to
the above procedure were made. After centrifugation of the Triton X-100
solubilized SR at 110,000  g for 15 min (Beckman bench top ultracen-
trifuge using a TLA-100.3 rotor), the pellet was resuspended at 1 mg/ml in
a solution containing 300 mM sucrose, 13 mM CaCl2, 20 mM MOPS-Tris
(pH 6.8) plus protease inhibitors (above). The resultant suspension was
homogenized in a dounce glass homogenizer and then centrifuged at
110,000  g for 15 min. The supernatant, containing calsequestrin, was
collected and after dialysis to remove residual Triton X-100, the final pellet
was suspended at an approximate concentration of 0.5 mg/ml in 20 mM
MOPS-Tris, 100 mM KCl, and 1 mM CaCl2, in small aliquots (100 l)
at 70°C
Electrophoresis and Western blotting
SDS-PAGE gels (6.5, 12, 5–17, or 3–12%) (Laemmli, 1970) were stained
with Commassie Brilliant Blue or silver stain, as appropriate. Proteins were
transferred onto Immobillon-P polyvinylidene difluoride (PVDF) transfer
membranes (Towbin et al., 1992). Either an alkaline phosphatase or horse-
radish peroxidase development system was used for immunodetection.
Single channel recording
Lipid bilayers were formed from phosphatidylethanolamine (PE), phos-
phatidylserine (PS), and PC (5:3:2 wt/wt) or PE and PC (8:2 wt/wt), across
a 200- to 250-m aperture in the wall of a delrin cup, separating trans
(luminal) and cis (cytoplasmic) solutions (Ahern et al., 1994), containing
cis: 230 mM Cs methanesulfonate (CsMS), 20 mM CsCl, 1 mM CaCl2, and
10 mM TES (pH 7.4); and trans: 30 mM CsMS, 20 mM CsCl, 1 mM
CaCl2, and 10 mM TES. SR vesicles were added to the cis solution.
Three-hundred millimolar mannitol was added to the cis chamber in some
experiments to aid incorporation. After incorporation 1) cis [Ca2] was
lowered to 100 nM with 4.5 mM 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-terra-acetic acid (BAPTA) to prevent further incorporation. Free
[Ca2] was calculated using the Bound and Determined program (Brooks
and Storey, 1992), 2) 2 mM Na-ATP was added to the cis solution, and 3)
200 mM CsMS added to the trans solution. During initial experiments 3
mM MgCl2 (1 mM free Mg
2) was included in the cis solution to mimic
the effects of free Mg2 in muscle. However, Mg2, a RyR inhibitor was
omitted from later experiments, to record measurable channel activity.
Solutions were changed by perfusion using back-to-back syringes. Poten-
tial was controlled and current recorded via an Axopatch 200A amplifier.
The potential of the trans solution was held at ground and the cis potential
varied. However potential is expressed conventionally as Vcis  Vtrans.
Currents were filtered at 1 kHz and digitized at 5 kHz. Single channel
parameters were obtained using the Channel 2 program (developed by
P.W. Gage and M. Smith, John Curtin School of Medical Research,
Canberra, Australia). Overall channel activity was measured by either
mean current (I, average of all data points obtained during a recording
period), relative mean current (It /Ic in which It is the mean current under
test conditions, and Ic is the mean current under control conditions) or
fractional mean current (IF, i.e., I divided by the maximal current Imax). A
half-amplitude detection method was used to determine channel open
probability (Po), opening frequency (Fo), mean open (To), and mean
intraburst closed times (Tc, a burst is defined as a group of sequential
openings terminated by a closed interval longer than 1 s). Channel activity
was analyzed over 30 s of continuous recording at 	40 mV with 250/250
mM Cs (cis/trans) or at 57 mV and 23 mV with 250/500 mM Cs.
In either case the membrane potential, Vm, was 40 mV positive or negative
to the current reversal potential, ECs, of the RyR (i.e., Vm  ECs  	40
mV).
Statistics
Average data are presented as mean 	 SE. The significance of differences
between control and test values were tested using a Student’s t-test for
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paired or independent data or a sign test (Minium et al., 1993), as appro-
priate.
RESULTS
Calsequestrin purification
JFM contained a 55-kDa protein corresponding to CSQ
(Fig. 1 A, lane 1). Exposure of JFM to a high salt solution
allowed isolation of this protein (Fig. 1 A, lane 2), which
was detected by the polyclonal anti-CSQ antibody (lane 3).
Approximately 5 mg of CSQ was purified from 200 g of
muscle. A faint band at 30 kDa on SDS-PAGE (not
apparent in Fig. 1 A), present after the first dialysis, was
removed by the second dialysis. The protein may be the
30-kDa luminal SR protein thought to regulate RyRs
(Yamaguchi et al., 1997). However, the presence of the
protein in some experiments (n  5) neither affected RyR
activity nor altered the channel’s response to CSQ.
RyR purification
SDS-PAGE of native SR showed a strong band at 400
kDa (presumably the RyR, Fig. 1 B, lane 1) and at 110
kDa (presumably Ca-ATPase). CHAPS-solubilized SR
showed a strong band at 400 kDa and a weak band at
110 kDa (Fig. 1 B, lane 2), indicating that the solubilized
fraction contained mostly RyR with some contaminant Ca-
ATPase. Immunoprobing the gels with anti-CSQ or antitria-
din antibodies showed that CSQ (Fig. 1 B, lane 3) and
triadin (lane 5) were present in native SR but were removed
in the solubilized fraction (lanes 4 and 6, respectively). A
faint band at 26 kD, which corresponds to junctin, can be
seen in the native SR (lane 1), which was not present in the
solubilized fraction (lane 2). When the solubilized fraction
was incorporated into bilayers, channel activity of 510 pS
was observed and responded to cytoplasmic Ca2, ATP and
ruthenium red in a similar way to native RyRs (data not
shown).
Response of RyR channels to increased
ionic strength
Channel activity is shown and analyzed at a potential 40 mV
positive to the current reversal potential (Materials and
Methods). Similar results were obtained at 40 mV negative
to the reversal potential under all conditions. The CSQ
purification method (above) was modified to dissociate
CSQ from SR in bilayers. RyR openings were infrequent
and brief in the presence of (cis) 250 mM Cs, 100 nM
Ca2, 2 mM ATP, and 3 mM Mg2 and (trans) 250 mM
Cs and 1 mM Ca2 (luminal control conditions) (Fig. 2 A),
but increased within 2 to 5 min after increasing trans ionic
strength to 500 mM (with 250 mM CsCl) (Fig. 2 B). The
trans ionic strength was then returned to 250 mM to deter-
mine whether the increased activity was due to increased
ionic strength per se or to an irreversible process, such as
CSQ dissociation. Channel activity remained high after
FIGURE 1 (A) SDS-PAGE (12%) showing a 55-kDa band in JFM (lane
1) and in supernatant after exposure of JFM to 500 mM NaCl (lane 2). The
band was identified as CSQ on Western blots using anti-CSQ antibody
(lane 3). The position of molecular weight markers is shown next to lane
1. Proteins were transferred onto Immobilon-P PVDF membranes before
probing with anti-CSQ. (B) Silver stain of SDS-PAGE (5–17%) showing a
110- and 400-kDa protein in native SR (lane 1) after purification of
RyRs (lane 2). The resolution of the silver stain in lane 2 has been
enhanced to illustrate the removal of all SR proteins (besides RyR and
Ca-ATPase) after the purification procedure. CSQ (lanes 3 and 4) and
triadin (lanes 5 and 6) were detected in native SR membranes (lanes 3 and
5) but not in purified RyR fractions (lanes 4 and 6) after Western blotting
with anti-CSQ or antitriadin antibodies. The protein located at 110 kDa
is presumed to be Ca-ATPase and the 400-kDa protein to be the RyR. The
position of molecular weight markers is shown next to lane 1. There was
no band at 26 kDa (lane 2) that would correspond to junctin.
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perfusion (Fig. 2 C) and repeated exposure to 500 mM trans
Cs (Fig. 2 D) and reperfusion with 250 mM Cs (Fig. 2
E).
Activity in one of six channels did not change upon
exposure to high trans ionic strength. In the other five
channels, initial exposure to 500 mM Cs increased Po and
To with significant increases in both average parameter
values for the six channels (Fig. 2, F and G). Although Fo
fell in four of the six channels and Tc fell in four channels,
average Fo and Tc did not change significantly (Fig. 2, H
and I). Single channel conductance at positive bilayer po-
tentials did not change when increasing trans [Cs] from
250 to 500 mM, Imax was 11.3	 0.7 pA (n 10) before and
12.1 	 0.9 pA after exposure to high ionic strength. Po and
To remained significantly higher than control when trans
ionic strength was subsequently varied between 250 and
500 mM. An irreversible increase in channel activity caused
by the initial increase in trans ionic strength was consistent
with CSQ dissociation. Presumably, once dissociated, CSQ
did not reassociate with RyRs 1) because it was immedi-
ately diluted in the trans solution, and 2) it was further
diluted with perfusion of the trans bath.
Reassociation of calsequestrin
If the increased RyR activity after exposure to high ionic
strength was due to CSQ dissociation, addition of excess
CSQ should then reduce channel activity. Activity fell in
each of five bilayers (containing one or two channels) when
20 g of purified CSQ was added to trans solutions con-
taining 250 mM Cs after they had been activated with 500
mM Cs (Fig. 3, A–D). It seems extremely unlikely that this
reduction in channel activity is a result of CSQ chelating
Ca2, thereby lowering [Ca2]free to levels such that a direct
Ca2-induced RyR inhibition was observed. CSQ (stored in
1 mM Ca2), which can bind 900 nmol Ca2/mg (Camp-
bell, 1986), would produce an insignificant reduction in
[Ca2]free (1 mM to over 0.999 mM). RyR activity that
increased after initial exposure to high ionic strength then
decreased significantly upon CSQ addition (Fig. 3 D). IF
(relative mean current, see Materials and Methods and Fig.
3 legend) increased threefold upon exposure to 500 mM
Cs and was restored to control levels upon CSQ addition.
The values of IF were 0.11 	 0.02 under control condi-
tions, 0.40	 0.10 with 500 mM CsCl, and 0.15	 0.04 with
20 g CSQ. This result is consistent with the initial increase
in activity being due to CSQ dissociation. Activity in an-
other four bilayers did not increase with the initial increase
in trans [Cs], but CSQ (20 g) still inhibited channels in
all four experiments. IF was 0.37 	 0.03 under control
conditions, 0.33 	 0.02 with 500 mM CsCl, and 0.05 	
0.02 with 20 g CSQ. These channels, and the unresponsive
channel in the previous section, may have initially lacked
associated CSQ.
Effect of anticalsequestrin antibody on
RyR activity
A polyclonal antibody to CSQ (0.5 g/ml trans) inhibited
five of eight RyRs (Fig. 4, A and B) with significant reduc-
tions in Po and Fo and an increase in Tc (Fig. 4, C, E, and
F). CSQ may not have been associated with the three
channels that were not inhibited by either 5 or 50 g/ml
antibody. In control experiments, the anti-CSQ storage
buffer (0.62 mM NaN3) alone did not alter RyR activity
when added to the trans chamber. IF was 0.23	 0.05 under
FIGURE 2 Increasing trans ionic strength to 500 mM causes an irreversible increase in single RyR channel activity. Vm  ECs was 40 mV under all
conditions. Single channel opening is upward from the zero current level (continuous line) to the maximal open conductance (broken line). The solutions
contained: cis 100 nM free Ca2(1 mM CaCl2 plus 4.5 mM BAPTA), 2 mM ATP, 3 mM MgCl2, and 250 mM Cs
; trans 250 or 500 mM Cs and 1 mM
CaCl2. (A) Control activity with 250 mM trans Cs
; (B) after increasing trans Cs to 500 mM with CsCl; (C) perfusing the trans chamber with 250 mM
Cs; (D and E) repeat of B and C. (A–E) Trans [Cs] is shown above each record. (F–I) Average data (n  5) for Po (F), To (G), Fo (H), and Tc (I) under
conditions shown in A through E. Asterisks (*) indicate average values significantly different from control.
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control conditions and 0.27	 0.04 with NaN3 (n 4). Note
that Mg2 was not present in the cis chamber during these
experiments, so that the Po and Fo values obtained here
were higher than those obtained from channels in the pres-
ence of Mg2 (Fig. 2, F and H).
The antibody did not alter activity in 10 of 10 RyRs when
added to the trans solution after treatment with 500 mM
trans Cs (Fig. 5). IF in one channel, which possibly lacked
CSQ, was 0.24 under control conditions, 0.24 in 500 mM
Cs, and 0.23 with antibody. Conversely, RyR activity fell
in each of three experiments in which RyRs were exposed to
antibody (0.5 g/ml) after they had been exposed to 500
mM trans Cs and then to 20 g of purified CSQ. IF fell
from 0.05 	 0.02 to 0.016 	 0.007. Together these results
1) suggest that the antibody inhibited RyRs by binding to
CSQ and 2) confirm that the high ionic strength solution
dissociated CSQ from the RyR complex.
Some RyR channels may not have associated
calsequestrin under control conditions
If RyRs that failed to respond either to an increase in trans
ionic strength or to anti-CSQ antibody, lacked associated
CSQ under initial control conditions, they should have had
higher control activity than responsive channels, because
activity increased when CSQ was removed (above results).
A plot of IF for 33 responsive and 18 unresponsive chan-
nels (Fig. 6) shows mostly greater activity in unresponsive
than in responsive channels. Unresponsive RyRs had a
significantly (p  1013) higher average IF (0.38 	 0.03)
than responsive RyRs (0.14 	 0.01), indicating two popu-
lations of RyRs.
We further tested the hypothesis that channels with low
activity contained associated CSQ, by exposing channels to
CSQ (20 g trans). Low activity channels did not show any
FIGURE 3 Excess CSQ reverses the increase in RyR activity seen with
high ionic strength. Vm  ECs was 40 mV under all conditions, and
channel opening is upward from the zero current (continuous line) to the
maximal open conductance (broken line). Solutions contained cis 100 nM
Ca2, 2 mM ATP, and 250 mM Cs; trans, 250 or 500 mM Cs and 1 mM
CaCl2. (A) Control channel activity; (B) after increasing trans Cs
 to 500
mM; (C) after trans perfusion with 250 mM Cs; and (D) addition of 20
g of trans CSQ. In A through D, [Cs]s cis/trans are shown for each
record. (E) Average data (n  5) for the relative mean current (It/Ic) under
conditions in A through D (It/Ic is defined in Materials and Methods). *,
Significant increase in It/Ic with 500 mM Cs
 and perfusion; **, significant
fall after adding CSQ.
FIGURE 4 Anti-CSQ antibody reduces single RyR channel activity.
Vm ECs was at40 mV, single channel opening is upward from the zero
current (continuous line) to the maximal open conductance (broken line).
The solutions contained: cis 100 nM Ca2, 2 mM ATP, and 250 mM Cs;
trans, 250 mM Cs and 1 mM CaCl2. (A) Single channel activity under
control conditions; (B) after adding 0.5 g/ml anti-CSQ to the trans
solution. In A and B, [Cs]s cis/trans are shown above each record; (C–F)
average data (n  5) for Po (C), To (D), Fo (E), and Tc (F) under control
conditions (con) and after adding anti-CSQ antibody (a-C). *, Average
values significantly different from control.
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further reduction in channel activity with CSQ addition
(four of four channels), whereas high activity channels
showed a reduction in activity (six of six channels). This
was consistent with added CSQ associating only with those
channels that lacked CSQ (i.e., high activity channels) and
the hypothesis that high activity channels lacked CSQ.
High luminal Ca2 concentrations also cause an
irreversible increase in RyR activity
Like high ionic strength, luminal Ca2 concentrations
greater than 10 mM have been reported to prevent the
interaction between CSQ and triadin and CSQ and junctin
(Zhang et al., 1997). We also found that there were no
detectable levels of CSQ after JFM had been exposed to 13
mM Ca2 (Fig. 7, lanes 3 and 6), suggesting that CSQ had
FIGURE 6 Control activity of single RyR
channels that respond to procedures that influ-
ence CSQ is lower than control activity of re-
sponsive channels. Control mean current as a
fraction of maximal current (IF) is shown.
Channels whose activity increased with 500 mM
trans Cs (CSQ dissociation) or decreased with
trans anti-CSQ antibody are numbered 1 to 33
(empty bars); channels that showed no consis-
tent change in IF after either exposure to 500
mM trans Cs or 0.5 g/ml trans anti-CSQ are
numbered 34 to 51 (shaded bars). The Student’s
t-test indicates that there are two populations of
RyR channel (see Results).
FIGURE 5 Anti-CSQ antibody does not alter activity in CSQ-depleted
single RyRs. Vm  ECs was 40 mV, single channel opening is upward
from zero current (continuous line) to the maximal open conductance
(broken line). The solutions contained: cis 100 nM Ca2, 2 mM ATP, 3
mM MgCl2 (in 2 of 10 experiments) and 250 mM Cs
; trans, 250 or 500
mM Cs and 1 mM CaCl2. (A) Control channel activity; (B) after increas-
ing trans Cs to 500 mM; (C) after adding 0.5 g/ml anti-CSQ to the trans
chamber. (D) Average relative mean current, It/Ic, (n  10) under condi-
tions in A through C. *, There is a significant increase in ItIc above after
increasing trans ionic strength to 500 mM.
FIGURE 7 Increasing [Ca2] from 1 to 13 mM removed CSQ from the
JFM. SDS-PAGE (5–17%) showing a 55-kDa band in JFM (lane 1) and in
a purified CSQ fraction (lane 2) but virtually absent from JFM after
exposure to 13 mM Ca2 (lane 3). This band was confirmed as CSQ in
heavy SR and purified CSQ fractions after Western blotting with anti-CSQ
(lanes 4 and 5). No CSQ was detectable in the JFM pellet after exposure
to 13 mM Ca2 (lane 6). Proteins were transferred onto Immobilon-P
PVDF membrane before probing with antibody. Note the very faint band
at 55 kDa in JFM after exposure to 13 mM Ca2 (lane 3, arrowhead), so
that a small fraction of CSQ remained associated with the JFM after
exposure to 13 mM Ca2. Western blotting with anti-CSQ did not reveal
the presence of CSQ in this band.
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dissociated from the JFM. It is unlikely that a significant
fraction of the CSQ was lost due to proteolytic degradation
because proteolytic inhibitors were present throughout the
isolation procedure (Materials and Methods).
The effect of high luminal [Ca2] on the RyR-CSQ
complex and RyR activity was examined by exposing single
RyRs to 13 mM trans Ca2. The time course of the response
of RyRs showed two distinct phases: an immediate increase
in activity followed by a slower increase after longer expo-
sure to high [Ca2] (Fig. 8). The increase in activity was
characterized by significant increases in average po, To, and
Fo and a decline in Tc. When trans Ca
2 was returned to 1
mM, the channel activity fell significantly but did not return
to its original level. However, addition of 20 g/ml of
purified CSQ to the trans chamber did cause a further
reduction in activity to control levels. Because we have
shown that addition of exogenous CSQ does not alter the
activity of channels that are already associated with CSQ
(above results), the CSQ-induced reduction in activity seen
here provides additional evidence that high luminal Ca2
had dissociated CSQ from the RyR complex.
To investigate the role of CSQ in the lumen on Ca2-
dependent activation of RyRs, we measured the effect of
high luminal [Ca2] on RyRs after CSQ had been removed
by exposure to an ionic strength of 500 mM. Exposure to
high luminal ionic strength produced a 1.8-fold increase in
RyR activity, and increasing luminal [Ca2] to 13 mM then
increased channel activity further. However, in contrast to
the RyR-CSQ complex, the time course of activation of
CSQ-depleted RyRs after an increase in luminal Ca2
showed only a single, rapid phase with no slow phase.
When trans [Ca2] was raised to 13 mM, RyRs activity
increased within 20 s and did not increase further in activity
over the next 5 min (Fig. 9). Returning [Ca2] to 1 mM by
either perfusion of the trans chamber or the addition of 12
mM BAPTA, returned RyR activity to that seen before the
increase in luminal [Ca2], but not to the low levels seen
before dissociation of CSQ. Thus the different effects of
luminal Ca2 on RyR with and without CSQ indicates that
1) luminal Ca2 activates RyRs by both CSQ dependent and
independent mechanisms and 2) that CSQ dissociation un-
derlies the slower component of RyR activation. The rela-
tively slow secondary increase in RyR activity with high
[Ca2] was similar to the slow increase in activity observed
during ionic strength, suggesting that, in both cases, CSQ
dissociation from the RyR complex takes 2 to 3 min.
Effects of calsequestrin on purified RyRs
The decrease in activity seen when CSQ is added to the
luminal (trans) solution could have been due to CSQ bind-
ing to the RyR directly or to CSQ affecting the RyR after
binding to triadin and junctin. To test these possibilities we
used RyR purification, to remove triadin, CSQ, and presum-
ably junctin (Fig. 1). Adding either 20 or 50 g/ml of CSQ
to purified RyRs either increased activity (n  3, It /Ic 
3.34	 1.65) or caused no significant change (n 2, It/Ic
0.96 	 0.012) in activity. The combined data for all five
channels indicates an insignificant increase in activity (It/Ic
 2.38 	 0.80). Thus purified RyRs were not inhibited by
CSQ, if anything they tended to be activated. The lack of
FIGURE 8 Increasing trans Ca2 from 1 to 13 mM causes an increase in single RyR channel activity, which can only be fully reversed by adding excess
CSQ to the solution. Vm ECs was40 mV under all conditions. Single channel openings are upward from zero current (continuous line) to maximal open
conductance (broken line). Solutions contained: cis, 100 nM Ca2, 2 mM ATP and 250 mM Cs; trans, 1 or 13 mM Ca2 and 250 mM Cs. (A) Control
channel activity with 1 mM trans Ca2; (B) 30 s after increasing trans Ca2 to 13 mM; (C) 3 min after increasing trans Ca2 to 13 mM; (D) after perfusing
trans chamber with 1 mM Ca2; (E) addition of trans 20 g/ml CSQ. F through I are average single channel parameter values (n  6) for po (F), To (G),
Fo (H), and Tc (I) under conditions shown in A through E. The * (t-test) indicates average values significantly different from control, ** (t-test) and
cross-hatch (##) (sign test) indicate values that are significantly different from the preceding condition.
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inhibition with purified RyRs is consistent CSQ requiring
anchoring protein(s) to mediate its inhibitory effect.
DISCUSSION
Our results show that association of CSQ with the native
RyR complex in lipid bilayers decreases channel activity.
These results were obtained in the presence of ATP and
Ca2 concentrations which are present in resting muscle.
We show that high luminal ionic strength (500 mM trans) or
high luminal [Ca2] (13 mM), both of which dissociate
CSQ from the JFM, cause an increase in RyR activity. In
addition, our results suggest that the actions of CSQ on RyR
activity depend on the presence of at least one coprotein
(probably junctin and/or triadin) in the RyR complex. This
is the first study to examine changes in channel activity
during dissociation and reassociation of the Ca2 binding
protein.
Dissociation CSQ from RyRs
Several lines of evidence are presented that support the
hypothesis that CSQ dissociation from the RyR complex
can lead to an increase in channel activity. 1) Sixty-five
percent of RyRs, initially observed with low activity, ex-
hibited an increase in activity when exposed to high luminal
(trans) ionic strength (Fig. 2). Lowering the ionic strength
did not reverse the increase, but it was reversed by adding
CSQ to the trans bath (Fig. 3). 2) These low activity RyRs
were also activated when trans (luminal) [Ca2] was in-
creased to concentrations known to dissociate CSQ from
triadin and junctin (Figs. 7 and 8) (Zhang et al., 1997). Once
again, adding CSQ reversed the effects. 3) Thirty-five per-
cent of RyRs that were initially observed with high activity
were unaffected by high ionic strength, but their activity
could be lowered by adding CSQ. 4) An antibody that binds
specifically to CSQ (Fig. 1) only affected RyR activity
under conditions where it was expected that CSQ was
associated with the RyR. For example, anti-CSQ antibody
did not affect RyR activity after high ionic strength treat-
ment (Fig. 5), but it did reduce activity if added after
addition of CSQ. It is not clear how anti-CSQ caused the
large decrease in RyR activity. Wang et al. (2001) have also
reported the anti-CSQ antibody can reduce RyR activity.
Regardless of the mechanism of action, anti-CSQ presum-
ably exerted its effect by binding to CSQ and provides an
additional method for confirming the presence of CSQ in
the RyR complex.
Calsequestrin-depleted RyRs
Our results suggest that a discrete population of 35% of
RyRs did not initially have CSQ attached, because they did
not respond to either high ionic strength or the anti-CSQ
antibody. The absence of CSQ was not due to a lack of the
necessary accessory protein (likely to be junctin/triadin),
because channel activity fell after excess CSQ addition,
showing that CSQ could bind and regulate channels. Our
results alone do not show whether some RyRs lacked CSQ
in vivo (suggested by Yamaguchi et al., 1997) or whether
CSQ was dissociated during preparation of SR vesicles. It is
possible that increasing luminal ionic strength from 50 to
250 mM before control recordings may have caused some
dissociation, because 250 mM is higher than the ionic
strength in vivo (150 mM). If RyRs are partially depleted
of CSQ in vivo, this would provide an explanation for the
observation by Wang et al. (2000) that cardiac myocytes
that over express CSQ have impaired Ca2 release and a
reduction of spontaneous Ca2 sparks (i.e., reduced RyR
FIGURE 9 Addition of 13 mM Ca to the trans bath induces an imme-
diate RyR activation in the absence of CSQ. Vm  ECs was 40 mV
under all conditions. Channel openings are upward from the zero current
level (continuous line) to the maximal open conductance (broken line) of
each of two channels (O1 and O2). The solutions contained: cis 100 nM
Ca2, 2 mM ATP and 250 mM Cs; trans 250 or 500 mM Cs and 1 or
13 mM CaCl2. (A) Control activity with 250 mM trans Cs
; (B) after
increasing trans Cs to 500 mM; (C) [Ca2] increase from 1 mM to 13
mM; (D) reducing [Ca2] back to 1 mM; (E) relative mean current (It/Ic)
n  4 for A through C, n  3 for D and n  1 for E, under conditions
shown in A through E. Asterisks (*) indicate average values significantly
different from control.
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activity). Although protein over expression may induce
nonspecific changes, it is interesting to speculate that some
RyRs in cardiac myocytes that originally lacked CSQ, may
be inhibited when CSQ was over expressed, because we
observe CSQ-induced inhibition only in RyRs that lack
CSQ.
The absence of CSQ in some cases provides additional
insight into the marked heterogeneity commonly observed
in RyR activity (Laver et al., 1995; Copello et al., 1997).
The variation in activity within the CSQ-depleted and CSQ-
replete RyR groups was less than the variability of the total
RyR population, indicating that differences in CSQ status is
an important factor in RyR variation. The variability ob-
served within the two RyR groups may stem from RyRs that
are differently coupled to other accessory proteins, known
to affect RyR function, such as dihydropyridine receptor
(Melzer et al., 1995), calsequestrin (Kawasaki and Kasai,
1994), FK506-binding (Timerman et al., 1993; Ahern et al.,
1994), and calmodulin (Tripathy et al., 1995).
Different effects of CSQ on activity of native and
purified RyRs
CSQ decreased the activity of native RyRs incorporated into
bilayers from SR vesicles. However, with CHAPS solub-
lized RyRs CSQ produced either no effect (n 2) or caused
a threefold increase in activity (n 3). Because of the large
difference between the two types of response, the combined
mean (n  5) showed a twofold activation that was not
significant. None-the-less, these findings are not inconsis-
tent with the CSQ-induced activation of purified RyRs
reported by Szegedi et al. (1999). The different effects of
CSQ seen in our experience may reflect differences in the
phosphorylation state of each CSQ molecule that binds to
the RyR (see below).
Different effects of CSQ on activity of native and purified
RyRs suggest that the CSQ effect is somehow dependent on
the composition of the RyR complex. For example, CHAPS
may have removed a necessary coprotein from the RyR
complex. Because triadin and junctin bind to both the RyR
and CSQ (Zhang et al., 1997) and these proteins are absent
in our purified RyRs (Fig. 1 B), it is likely that one or both
triadin and junctin mediate the CSQ effect. Indeed, it has
been shown that triadin modifies the effect of CSQ on RyR
activity (Ohkura et al., 1998). The in vivo action of junctin/
triadin on RyRs is not known, although the activity of
purified RyRs is decreased by triadin (Ohkura et al., 1998;
Groh et al., 1999) and peptides corresponding to the cyto-
plasmic domain of triadin inhibit RyR activity (Caswell et
al., 1999; Groh et al., 1999). This indicates that the func-
tional interaction between the proteins occurs on the cyto-
plasmic side of the membrane. In the light of these findings,
we suggest that CSQ binding to the luminal domain of
triadin somehow influences the interaction between its cy-
toplasmic domain and the RyR, enabling triadin to further
inhibit RyR activity.
There have been conflicting reports of the effect of CSQ
on single native RyR channels and 3H-ryanodine binding.
CSQ decreases RyR activity here (for preliminary reports,
see Beard et al., 1999, 2000; Wang et al., 2001). In contrast,
other studies show that CSQ increases both RyR activity
and 3H-ryanodine binding (Kawasaki and Kasai, 1994; Oh-
kura et al., 1995, 1998; Szegedi et al., 1999). It is unlikely
that the conflicting reports of CSQ action on RyR are due
simply to the incorporation of the RyR complex into an
artificial membrane because this study and the studies of
Kawasaki and Kasai (1994) and Ohkura et al. (1995) all
used the lipid bilayer technique. A more likely explanation
is that an essential coprotein remains associated with RyRs
after the relatively mild dissociating procedures used here
and by Wang et al. (2001) but was not present in other
studies. Exposure to 500 mM trans Cs (with 1 mM trans
Ca2) or high (13 mM) luminal Ca2 can disrupt charge-
charge interactions between CSQ and junctin/triadin (Zhang
et al., 1997; Kawasaki and Kasai, 1994; Ikemoto et al.,
1989) and thus may dissociate CSQ, while leaving other
RyR coproteins in place (Fig. 1, lane 2). On the other hand,
many proteins in addition to CSQ, including triadin and
junctin, are dissociated from the SR by incubation with
EGTA and CHAPS (Kawasaki and Kasai, 1994; this study).
Dissociation of an anchoring protein would account for the
failure of CSQ to inhibit channel activity after incubation
with EGTA or CHAPS.
The phosphorylation status of CSQ is important in deter-
mining the effect of CSQ on CHAPS purified RyRs
(Szegedi et al., 1999). Dephosphorylated CSQ was able to
induce an almost fivefold Po increase, whereas the phos-
phorylated CSQ did not activate the RyR. Furthermore,
Varsanyi and Heilmeyer (1980) report that CSQ is isolated
in its phosphorylated form. Thus it is likely that a fraction of
the CSQ used in this study is phosphorylated; some purified
RyRs examined were unaffected by CSQ (i.e., the bound
CSQ may have been phosphorylated), whereas others
showed threefold activation (CSQ may not have been phos-
phorylated).
Regulation of RyRs by luminal [Ca2]
The level of Ca2 loading of the SR is important in regu-
lating Ca2 release. Increasing or decreasing SR Ca2 load
increases or decreases (respectively) the sensitivity of Ca2
release in response to depolarization (Bassani et al., 1995;
Lamb et al., 2001), cytoplasmic Ca2 (Copello et al., 1997),
caffeine (Lamb et al., 2001), ATP (Donoso et al., 1995), and
polylysine (Saiki and Ikemoto, 1999). Moreover, Lamb et
al. (2001) find that endogenous levels of SR Ca2 loading
in fast (extensor digitorum longus (EDL)) and slow twitch
(soleus) muscle is the primary factor determining the dif-
ference in caffeine sensitivities in the two fiber types. How-
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ever, it is not clear how the Ca2 load in the SR alters Ca2
release.
These effects of SR Ca2 load on Ca2 release are also
reflected in single RyR channel studies. Luminal Ca2
increases channel activity in both purified (Tripathy and
Meissner, 1996) and native RyRs (Sitsapesan and Williams,
1995; Beard et al., 2000). This increase in activity has been
attributed to Ca2 flowing from the luminal solution,
through the channel, and binding to Ca2 activation sites on
the cytoplasmic side of the RyR (Tripathy and Meissner,
1996). An alternative hypothesis is that luminal Ca2 is
sensed by regulatory sites on the luminal side of the RyR
(Sitsapesan and Williams, 1995; Ching et al., 2001). Be-
cause these bilayer studies were performed under conditions
where CSQ (and possibly triadin and junctin) were not
likely to have been present, regulation by CSQ bound to
triadin/junctin can be discounted. Triadin and junctin were
not present when RyRs were purified using CHAPS solub-
lization (Tripathy and Meissner, 1996). Evidence suggests
that CSQ may not have been present when native RyRs
were incorporated into bilayers in the absence of luminal
Ca2 (Kawasaki and Kasai, 1994; Sitsapesan and Williams,
1995; Wang et al., 1998; Ching et al., 2001).
It has been proposed in other studies that CSQ is involved
in RyR regulation by luminal Ca2 (for review, see Donoso
et al., 1995). SR Ca2 release is most sensitive to luminal
Ca2 over the same range of Ca2 (0–2 mM) that induces
substantial, reversible conformational changes in CSQ (Ike-
moto et al., 1989; He et al., 1993). We present evidence that
high levels of luminal [Ca2] can activate RyRs by at least
two mechanisms, one that is independent of calsequestrin
and another that involves CSQ dissociation from the RyR
complex. Raising [Ca2] from 1 to 13 mM dissociates CSQ
from the JFM (Fig. 7), inducing a 2.4-fold rise in RyR
activity, which could be fully reversed by adding back CSQ
(Fig. 8). Wang et al. (2001) also found that 10 mM Ca2
induces a 2.1-fold increase in po of cardiac RyRs in bilayers.
These, and our studies are consistent with previous findings
that high luminal [Ca2] disrupts the charge-charge inter-
actions binding triadin, junctin, and CSQ (Mitchell et al.,
1988; Zhang et al., 1997). Presumably the CSQ-indepen-
dent mechanism is due to a direct activation of the RyR by
luminal Ca2 seen in single channel studies (see above).
The role of CSQ in RyR function in vivo is not clear.
CSQ might regulate RyRs via dissociation of CSQ, al-
though, it is not likely that the dissociation of CSQ from the
JFM would be caused by normal physiological changes in
luminal [Ca2] and so may not be an important mechanism
in vivo. However, levels of luminal Ca2 of 10 mM are
obtained experimentally when loading the SR to above
normal levels (Lamb et al., 2001), and such loading leads to
enhanced Ca2 release. Whether this occurs due to CSQ
dissociation from the JFM or another mechanism remains to
be investigated. It is also possible that luminal Ca2 can
also regulate RyR activity via Ca2-induced changes in
CSQ conformation within the physiological range of lumi-
nal Ca2. These changes in RyR activity may be more
subtle than the gross changes that we see with CSQ disso-
ciation. Thus, like calmodulin, which modifies RyR regu-
lation in a manner dependent on cytoplasmic [Ca2] (Tri-
pathy and Meissner, 1995), CSQ may be an important
coprotein, modifying RyR function in a luminal [Ca2]-
dependent way. Finally, given that triadin binds to both
CSQ and to the cytoplasmic side of the RyRs (Groh et al.,
1999), it is possible that triadin forms part of the signaling
pathway by which CSQ can communicate information
about the level of luminal Ca2 to the RyR.
We thank Suzi Pace and Joan Stivala for assistance with SR vesicle
preparation and for advice with CSQ isolation, SDS-PAGE, and Western
blotting. We also thank Kevin Campbell for the kind donation of the
antitriadin antibody.
This work was supported by a grant from the National Health and Medical
Research Council of Australia (9936486 to D. R. L.).
REFERENCES
Ahern, G. P., P. R. Junankar, and A. F. Dulhunty. 1994. Single channel
activity of the ryanodine receptor calcium release channel is modulated
by FK-506. FEBS Lett. 352:369–374.
Bassani, J. W., W. Yuan, and D. M. Bers. 1995. Fractional SR Ca release
is regulated by trigger Ca and SR Ca content in cardiac myocytes.
Am. J. Physiol. 268:C1313–C1319.
Beard, N. A., A. F. Dulhunty, and D. R. Laver. 2000. The effect of
increasing luminal calcium on skeletal muscle calsequestrin. Proc. Aust.
Physiol. Pharmacol. Soc. 21:23.
Beard, N. A., D. R. Laver, and A. F. Dulhunty. 1999. Regulation of skeletal
muscle ryanodine receptors by calsequestrin. Proc. Aust. Physiol. Phar-
macol. Soc. 201:30–43.
Brooks, S. P., and K. B. Storey. 1992. Bound and determined: a computer
program for making buffers of defined ion concentrations. Anal. Bio-
chem. 119–126.
Campbell, K. P. 1986. Protein components and their roles in sarcoplasmic
reticulum function. In Sarcoplasmic Reticulum in Muscle Physiology,
Vol. 1. M. L. Entman and W. B. Van Winkle, editors. CRC Press, Boca
Raton, FL. 65–99.
Caswell, A. H., H. K. Motoike, H. Fan, and N. R. Brandt. 1999. Location
of ryanodine receptor binding site on skeletal muscle triadin. Biochem-
istry. 38:90–97.
Ching, L. L., A. J. Williams, and R. Sitsapesan. 2001. Evidence for Ca2
activation and inactivation sites on the luminal side of the cardiac
ryanodine receptor complex. Circ. Res. 87:201–206.
Copello, J. A., S. Barg, H. Onoue, and S. Fleischer. 1997. Heterogeneity of
Ca2 gating of skeletal muscle and cardiac ryanodine receptors. Bio-
phys. J. 73:141–156.
Costello, B., C. Chadwick, A. Saito, A. Chu, A. Maurer, and S. Fleischer.
1986. Characterization of the junctional face membrane from terminal
cisternae of sarcoplasmic reticulum. J. Cell. Biol. 103:741–753.
Donoso, P., H. Prieto, and C. Hidalgo. 1995. Luminal calcium regulates
calcium release in triads isolated from frog and rabbit skeletal muscle.
Biophys. J. 68:507–515.
Franzini-Armstrong, C., L. J. Kenney, and E. Varriano Marston. 1987. The
structure of calsequestrin in triads of vertebrate skeletal muscle: a
deep-etch study. J. Cell. Biol. 105:49–56.
Groh, S., I. Marty, M. Ottolia, G. Prestipino, A. Chapel, M. Villaz, and M.
Ronjat. 1999. Functional interaction of the cytoplasmic domain of tria-
din with the skeletal ryanodine receptor. J. Biol. Chem. 274:
12278–12283.
Calsequestrin Inhibits RyRs 319
Biophysical Journal 82(1) 310–320
Guo, W., A. O. Jorgensen, and K. P. Campbell. 1996. Triadin, a linker for
calsequestrin and the ryanodine receptor. Soc. Gen. Physiol. Ser. 51:
19–28.
He, Z., A. K. Dunker, C. R. Wesson, and W. R. Trumble. 1993. Ca2-
induced folding and aggregation of skeletal muscle sarcoplasmic retic-
ulum calsequestrin: the involvement of the trifluoperazine-binding site.
J. Biol. Chem. 268:24635–24641.
Herzog, A., C. Szegedi, I. Jona, F. W. Herberg, and M. Varsanyi. 2000.
Surface plasmon resonance studies prove the interaction of skeletal
muscle sarcoplasmic reticular Ca2 release channel/ryanodine receptor
with calsequestrin. FEBS Lett. 472:73–77.
Ikemoto, N., G. M. Bhatnagar, B. Nagy, and J. Gergely. 1972. Interaction
of divalent cations with the 55,000-dalton protein component of the
sarcoplasmic reticulum: studies of fluorescence and circular dichroism.
J. Biol. Chem. 247:7835–7837.
Ikemoto, N., M. Ronjat, L. G. Meszaros, and M. Koshita. 1989. Postulated
role of calsequestrin in the regulation of calcium release from sarcoplas-
mic reticulum. Biochemistry. 28:6764–6771.
Jones, L. R., L. Zhang, K. Sanborn, A. O. Jorgensen, and J. Kelley. 1995.
Purification, primary structure, and immunological characterization of
the 26-kDa calsequestrin binding protein (junctin) from cardiac junc-
tional sarcoplasmic reticulum. J. Biol. Chem. 270:30787–30796.
Kawasaki, T., and M. Kasai. 1994. Regulation of calcium channel in
sarcoplasmic reticulum by calsequestrin. Biochem. Biophys. Res. Com-
mun. 199:1120–1127.
Kim, D. H., S. T. Ohnishi, and N. Ikemoto. 1983. Kinetic studies of
calcium release from sarcoplasmic reticulum in vitro. J. Biol. Chem.
258:9662–9668.
Knudson, C. M., K. K. Stang, C. R. Moomaw, C. A. Slaughter, and K. P.
Campbell. 1993. Primary structure and topological analysis of a skeletal
muscle-specific junctional sarcoplasmic reticulum glycoprotein (tria-
din). J. Biol. Chem. 268:12646–12654.
Kobayashi, Y. M., B. A. Alseikhan, and L. R. Jones. 2001. Localization
and characterization of the calsequestrin-binding domain of triadin 1:
evidence for a charged beta-strand in mediating the protein-protein
interaction. J. Biol. Chem. 275:17639–17646.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly
of the head of bacteriophage T4. Nature. 227:680–685.
Lai, F. A., H. P. Erickson, E. Rousseau, Q. Y. Liu, and G. Meissner. 1988.
Purification and reconstitution of the calcium release channel from
skeletal muscle. Nature. 331:315–319.
Lamb, G. D., M. A. Cellini, and D. G. Stephenson. 2001. Different Ca2
releasing actions of caffeine and depolarization in skeletal muscle fibres
of the rat. J. Physiol. 531:715–728.
Laver, D. R., L. D. Roden, G. P. Ahern, K. R. Eager, P. R. Junankar, and
A. F. Dulhunty. 1995. Cytoplasmic Ca2 inhibits the ryanodine receptor
from cardiac muscle. J. Membr. Biol. 147:7–22.
MacLennan, D. H., and P. T. Wong. 1971. Isolation of a calcium-
sequestering protein from sarcoplasmic reticulum. Proc. Natl. Acad. Sci.
U.S.A. 68:1231–1235.
Melzer, W., A. Herrmann-Frank, and H. C. Luttgau. 1995. The role of
Ca2 ions in excitation-contraction coupling of skeletal muscle fibres.
Biochim. Biophys. Acta. 1241:59–116.
Minium, E. W., B. M. King, and G. Bear. 1993. Statistical reasoning in
psychology and education. John Wiley and Sons, New York.
Mitchell, R. D., H. K. Simmerman, and L. R. Jones. 1988. Ca2 binding
effects on protein conformation and protein interactions of canine car-
diac calsequestrin. J. Biol. Chem. 263:1376–1381.
Ohkura, M., K. Furukawa, H. Fujimori, A. Kuruma, S. Kawano, M.
Hiraoka, A. Kuniyasu, H. Nakayama, and Y. Ohizumi. 1998. Dual
regulation of the skeletal muscle ryanodine receptor by triadin and
calsequestrin. Biochemistry. 37:12987–12993.
Ohkura, M., T. Ide, K. Furukawa, T. Kawasaki, M. Kasai, and Y. Ohizumi.
1995. Calsequestrin is essential for the Ca2 release induced by myo-
toxin alpha in skeletal muscle sarcoplasmic reticulum. Can. J. Physiol.
Pharmacol. 73:1181–1185.
Saiki, Y., and N. Ikemoto. 1999. Coordination between Ca2 release and
subsequent re-uptake in the sarcoplasmic reticulum. Biochemistry. 38:
3112–3119.
Saito, A., S. Seiler, A. Chu, and S. Fleischer. 1984. Preparation and
morphology of sarcoplasmic reticulum terminal cisternae from rabbit
skeletal muscle. J. Cell. Biol. 99:875–885.
Shin, D. W., J. Ma, and D. H. Kim. 2001. The asp-rich region at the
carboxyl-terminus of calsequestrin binds to Ca2 and interacts with
triadin. FEBS Lett. 486:178–182.
Sitsapesan, R., and A. J. Williams. 1995. The gating of the sheep skeletal
sarcoplasmic reticulum Ca2-release channel is regulated by luminal
Ca2. J. Membr. Biol. 146:133–144.
Szegedi, C., S. Sarkozi, A. Herzog, I. Jona, and M. Varsanyi. 1999.
Calsequestrin: more than “only” a luminal Ca2 buffer inside the sar-
coplasmic reticulum. Biochem. J. 337:19–22.
Timerman, A. P., E. Ogunbumni, E. Freund, G. Wiederrecht, A. R. Marks,
and S. Fleischer. 1993. The calcium release channel of sarcoplasmic
reticulum is modulated by FK-506-binding protein: dissociation and
reconstitution of FKBP-12 to the calcium release channel of skeletal
muscle sarcoplasmic reticulum. J. Biol. Chem. 268:22992–22999.
Towbin, H., T. Staehelin, and J. Gordon. 1992. Electrophoretic transfer of
proteins from polyacrylamide gels to nitrocellulose sheets: procedure
and some applications. Biotechnology. 24:145–149.
Tripathy, A., and G. Meissner. 1996. Sarcoplasmic reticulum luminal Ca2
has access to cytosolic activation and inactivation sites of skeletal
muscle Ca2 release channel. Biophys. J. 70:2600–2615.
Tripathy, A., L. Xu, G. Mann, and G. Meissner. 1995. Calmodulin acti-
vation and inhibition of skeletal muscle Ca2 release channel (ryanodine
receptor). Biophys. J. 69:106–119.
Varsanyi M. and L. M. Heilmeyer, Jr. 1980. Autocatalytic phosphorylation
of calsequestrin. FEBS Lett. 122:227–230.
Wang, J., N. A. Maertz, A. J. Lokua, E. G. Kranias, and H. H. Valdivia.
2001. Regulation of cardiac ryanodine receptors activity by calseques-
trin. Biophys. J. 80:590.
Wang, S., W. R. Trumble, H. Liao, C. R. Wesson, A. K. Dunker, and C. H.
Kang. 1998. Crystal structure of calsequestrin from rabbit skeletal mus-
cle sarcoplasmic reticulum. Nat. Struct. Biol. 5:476–483.
Wang, W., L. Cleemann, L. R. Jones, and M. Morad. 2000. Modulation of
focal and global Ca2 release in calsequestrin-overexpressing mouse
cardiomyocytes. J. Physiol. 524:399–414.
Yamaguchi, N., K. Igami, and M. Kasai. 1997. Kinetics of depolarization-
induced calcium release from skeletal muscle triads in vitro. J. Biochem.
(Tokyo). 121:432–439.
Yamaguchi, N., T. Kawasaki, and M. Kasai. 1995. DIDS binding 30-kDa
protein regulates the calcium release channel in the sarcoplasmic retic-
ulum. Biochem. Biophys. Res. Commun. 210:648–653.
Zhang, L., J. Kelley, G. Schmeisser, Y. M. Kobayashi, and L. R. Jones.
1997. Complex formation between junctin, triadin, calsequestrin, and the
ryanodine receptor: proteins of the cardiac junctional sarcoplasmic re-
ticulum membrane. J. Biol. Chem. 272:23389–23397.
320 Beard-Whalley et al.
Biophysical Journal 82(1) 310–320
